Among 284 patients in the 400 mg/day group in the FAS , 82 ( 28.9 % ) met 1 exit criterion ; the Kaplan-Meier-predicted exit percentage at day 112 for 400 mg/day ( 30.0 % ; 95 % confidence interval [ CI ] 24.6-35 .5 % ) was lower than the historical control .